BioCardia, Inc.
Developing regenerative cell therapies for cardiovascular and pulmonary diseases.
BCDA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US09060U5074
- LEI:
- Country:
- United States of America
- Address:
- 320 SOQUEL WAY, 94085 SUNNYVALE
- Website:
- https://www.biocardia.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioCardia, Inc. is a clinical-stage regenerative medicine company developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases with significant unmet medical needs. The company's product pipeline is centered on its investigational CardiAMP™ and CardiALLO™ cell therapy platforms. Its lead candidate, CardiAMP, is an autologous cell therapy in late-stage development for treating ischemic heart failure with reduced ejection fraction (HFrEF). BioCardia focuses on creating comprehensive biotherapeutic solutions that utilize proprietary delivery systems to administer treatments directly to the heart.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioCardia, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioCardia, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioCardia, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
